Day 1 - Morning

Group 1A: HER2+ Breast Cancer; Symptoms & Survivorship Last Few Tickets

Group 1B: HR+ Breast Cancer; Clinical Trials; Hormone Therapies Sold Out

Group 1C: Triple Negative Breast Cancer; Clinical Trials; Immunotherapy; Targeted Therapies

Group 1D: Breast & Pan-Cancers; Brain Metastasis; Tumor Biology Sold Out

Group 1E: Pan-Cancers; Healthcare Equity; Symptoms & Survivorship; Underserved Populations

Group 1F: Pan-Cancers; Clinical Trials; Symptoms & Survivorship